These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 91212)
1. Increased frequency of HLA--DRw2 and DRw3 in multiple sclerosis. de Moerloose P; Jeannet M; Martins-da-Silva B; Werner-Favre C; Rohr J; Gauthier G Tissue Antigens; 1979 May; 13(5):357-60. PubMed ID: 91212 [TBL] [Abstract][Full Text] [Related]
2. [HLA-DRW antigens and multiple sclerosis]. De Moerloose PH; Jeannet M; Martins-da-Silva B; Werner-Favre C; Rohr J; Gauthier G Schweiz Arch Neurol Neurochir Psychiatr; 1978; 123(1):51-61. PubMed ID: 83671 [TBL] [Abstract][Full Text] [Related]
3. HLA-DR antigens in Black North-Americans and their association with HLA-D. Duquesnoy RJ; Marrari M; Annen K; Pollack MS; Dupont B Tissue Antigens; 1979 Aug; 14(2):145-56. PubMed ID: 91224 [TBL] [Abstract][Full Text] [Related]
5. Association of histocompatibility haplotype HLA-A3-B7 with multiple sclerosis. Bertrams HJ; Kuwert EK J Immunol; 1976 Nov; 117(5 Pt.2):1906-12. PubMed ID: 993587 [TBL] [Abstract][Full Text] [Related]
6. Histocompatibility (HLA) antigens and multiple sclerosis in Israelis. Brautbar C; Amar A; Cohen I; Kahana E; Cohen T; Bloch D; Grosse-Wilde H; Alter M Isr J Med Sci; 1982 May; 18(5):631-4. PubMed ID: 7096048 [TBL] [Abstract][Full Text] [Related]
7. Cell-mediated cytotoxicity against HLA-D-region products expressed in monocytes and B lymphocytes. I. Blocking by Unlabelled cells and inhibition by antisera. Feighery CF; Stastny P Immunogenetics; 1980; 10(1):31-8. PubMed ID: 6157642 [TBL] [Abstract][Full Text] [Related]
8. [Complement markers Bf and C4 in multiple sclerosis]. Fauchet R; Madigand M; Gueguen-Duchesne MY; Papin J; Sabouraud O; Genetet B Rev Neurol (Paris); 1984; 140(6-7):422-5. PubMed ID: 6611572 [TBL] [Abstract][Full Text] [Related]
9. HLA antigen segregation analysis in multiple sclerosis (MS) families. Bertrams J; Kuwert E Z Immunitatsforsch Immunobiol; 1976 Nov; 152(3):200-8. PubMed ID: 1007375 [TBL] [Abstract][Full Text] [Related]
14. A linkage analysis of the Gm locus and multiple sclerosis. Haile RW; Goldstein A; Field L; Marazita ML Genet Epidemiol; 1985; 2(1):29-34. PubMed ID: 3876966 [TBL] [Abstract][Full Text] [Related]
15. B-lymphocyte alloantigens associated with multiple sclerosis. Compston DA; Batchelor JR; McDonald WI Lancet; 1976 Dec; 2(7998):1261-5. PubMed ID: 63743 [TBL] [Abstract][Full Text] [Related]
16. The association of HLA antigens A3, B7, and DW2 with 330 multiple sclerosis patients in the United States. Opelz G; Terasaki P; Myers L; Ellison G; Ebers G; Zabriskie J; Weiner H; Kempe H; Sibley W Tissue Antigens; 1977 Jan; 9(1):54-8. PubMed ID: 850918 [TBL] [Abstract][Full Text] [Related]
17. HLA profiles in multiple sclerosis suggest two forms of disease and the existence of protective haplotypes. Madigand M; Oger JJ; Fauchet R; Sabouraud O; Genetet B J Neurol Sci; 1982 Mar; 53(3):519-29. PubMed ID: 6978384 [TBL] [Abstract][Full Text] [Related]
18. Histocompatibility antigens (HLA) in multiple sclerosis in Iran. Lotfi J; Nikbin B; Derakhshan I; Aghai Z; Ala F J Neurol Neurosurg Psychiatry; 1978 Aug; 41(8):699-701. PubMed ID: 681957 [TBL] [Abstract][Full Text] [Related]
19. HLA and susceptibility to multiple sclerosis. Clerget-Darpoux F; Govaerts A; Feingold N Tissue Antigens; 1984 Sep; 24(3):160-9. PubMed ID: 6515632 [TBL] [Abstract][Full Text] [Related]
20. HLA-A, B and C and HLA-DR antigens in intrinsic and allergic asthma. Morris MJ; Faux JA; Ting A; Morris PJ; Lane DJ Clin Allergy; 1980 Mar; 10(2):173-9. PubMed ID: 7389070 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]